aid: regeneron
url: https://raw.githubusercontent.com/api-evangelist/regeneron/refs/heads/main/apis.yml
name: Regeneron
type: Index
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/apis-json-logo.jpg
tags:
  - Pharmaceutical
  - Biotechnology
  - Healthcare
  - Genomics
description: >-
  Regeneron Pharmaceuticals is a leading biotechnology company that invents,
  develops, and commercializes life-transforming medicines, including EYLEA
  and EYLEA HD for ophthalmology, Dupixent in immunology (co-developed with
  Sanofi), Libtayo and Lynozyfic in oncology and hematology, and Praluent
  for cardiovascular disease. Regeneron does not publish a public developer
  API; its Regeneron Genetics Center collaborates on large-scale genomic
  research via the UK Biobank, DiscovEHR, and partner platforms rather than
  a self-hosted API.
created: '2026-05-05'
modified: '2026-05-16'
specificationVersion: '0.19'
apis: []
common:
  - type: DomainSecurity
    url: security/regeneron-domain-security.yml
  - type: GitHubOrganization
    url: https://github.com/regeneron-mpds
  - type: LinkedIn
    url: https://www.linkedin.com/company/regeneron-pharmaceuticals
  - type: Website
    url: https://www.regeneron.com/
  - type: InvestorRelations
    url: https://investor.regeneron.com/
  - type: ClinicalTrials
    url: https://clinicaltrials.regeneron.com/
  - type: Careers
    url: https://careers.regeneron.com/
  - type: GeneticsCenter
    url: https://www.regeneron.com/science/regeneron-genetics-center
  - type: Vocabulary
    url: vocabulary/regeneron-vocabulary.yml
  - type: Features
    data:
      - name: Ophthalmology
        description: EYLEA and EYLEA HD anti-VEGF therapies for retinal diseases
      - name: Immunology
        description: Dupixent for atopic dermatitis, asthma, and other IL-4/IL-13 indications
      - name: Oncology and Hematology
        description: Libtayo, Lynozyfic, and pipeline programs in oncology
      - name: Rare Diseases
        description: Evkeeza, Veopoz, and other rare-disease therapies
      - name: Infectious Disease
        description: Inmazeb antibody cocktail for Ebola
      - name: Genetics Research
        description: Regeneron Genetics Center sequencing collaborations including UK Biobank
  - type: UseCases
    data:
      - name: Clinical Trial Discovery
        description: Patients and HCPs locate Regeneron-sponsored trials
      - name: Drug Information
        description: HCPs access prescribing information for Regeneron medicines
      - name: Genomic Discovery
        description: Researchers partner with the Regeneron Genetics Center on large-cohort sequencing
maintainers:
  - FN: Kin Lane
    email: kin@apievangelist.com